Early research/company pr/CRISPR Therapeutics

Gene-edited cell replacement

Gene editing could be the tool that finally makes immune-evasive cell therapy reliable. This program is early and tracked as a pipeline signal.

How it works

Uses gene editing to create insulin-producing cells engineered to hide from the immune system, with the goal of transplanting them without immune-suppressing drugs.

Approach

Gene-edited immune-evasive cells

Immunosuppression

Designed to avoid immunosuppression

Live trial status

No registered clinical trial is tracked for this program yet (it may be preclinical or early). See the official program links for the latest.

These are research programs pursuing a functional cure or disease modification for type 1 diabetes. None is a confirmed, broadly available cure. Trial status is informational, not medical advice, and not a recruiting offer. Verify eligibility and details with the official trial record and a clinician.

Family-tested T1D gear

Some links below are affiliate links. If you buy through them, Type1Cure may earn a small commission at no extra cost to you. Affiliate relationships never affect our research coverage, evidence labels, rankings, or safety alerts.

Daily gearCGM adhesive patchesKeep sensors on through sports, showers, and sweat. A daily-life staple for T1D families.Daily gearInsulated diabetes travel caseOrganize insulin, supplies, and a backup kit for school, travel, and emergencies.LowsFast-acting glucose tabletsA reliable low-treatment to keep in every bag, locker, and nightstand.LearningBooks on living with type 1Guides for newly-diagnosed families, teens, and caregivers learning the ropes.